Ondansetron Kent

Ondansetron, the active ingredient in Ondansetron Kent, is a antiemetic presented as a 4mg tablet for oral use. It helps prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery.

GNH USA supplies Ondansetron Kent as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron is used to manage nausea and vomiting associated with several clinical pathways. - Chemotherapy-induced nausea and vomiting (CINV): Reduces the frequency and severity of nausea and vomiting following cancer chemotherapy. - Radiation-induced nausea and vomiting (RINV): Helps prevent the onset of vomiting during radiation treatment. - Post‑operative post‑operative vomiting (PONV): Mitigates the risk of vomiting after surgical procedures. - Pregnancy t  ?? -  ???\n-  ??   g